{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T20:29:51Z","timestamp":1769545791964,"version":"3.49.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1R15GM10793-01A1"],"award-info":[{"award-number":["1R15GM10793-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-1021RR571424"],"award-info":[{"award-number":["R01-1021RR571424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.xphs.2018.02.019","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T23:06:39Z","timestamp":1519772799000},"page":"1937-1947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Conformationally Gated Model of Methadone and Loperamide Transport by P-Glycoprotein"],"prefix":"10.1016","volume":"107","author":[{"given":"Morgan E.","family":"Gibbs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Wilt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlyn V.","family":"Ledwitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur G.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.xphs.2018.02.019_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jemt.10090","article-title":"Functional expression and localization of P-glycoprotein at the blood brain barrier","volume":"57","author":"Bendayan","year":"2002","journal-title":"Microsc Res Tech"},{"issue":"8","key":"10.1016\/j.xphs.2018.02.019_bib2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1023\/B:PHAM.0000036905.82914.8e","article-title":"Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders","volume":"21","author":"Lee","year":"2004","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.019_bib3","first-page":"160","article-title":"The role of P-glycoprotein in the blood-brain barrier","volume":"19","author":"Ramakrishnan","year":"2003","journal-title":"Einstein QJ Biol Med"},{"issue":"3","key":"10.1016\/j.xphs.2018.02.019_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.102.039255","article-title":"Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and Non-CNS marketed drugs","volume":"303","author":"Doan","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"5922","key":"10.1016\/j.xphs.2018.02.019_bib5","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.xphs.2018.02.019_bib6","series-title":"Critical Pathways to Success in CNS Drug Development","first-page":"1","article-title":"The impending crisis in CNS drug development","author":"Cutler","year":"2010"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0972-2327.53076","article-title":"Role of multidrug transporters in neurotherapeutics","volume":"12","author":"Jose","year":"2009","journal-title":"Ann Indian Acad Neurol"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.019_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/scientificamerican0811-16","article-title":"A\u00a0dearth of new meds","volume":"305","author":"Kaitin","year":"2011","journal-title":"Sci Am"},{"issue":"3","key":"10.1016\/j.xphs.2018.02.019_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/15680096113139990076","article-title":"P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives","volume":"13","author":"Binkhathlan","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.019_bib10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","article-title":"Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?","volume":"42","author":"Callaghan","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/pr.107.07109","article-title":"Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy","volume":"60","author":"Miller","year":"2008","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.019_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/mol.116.104190","article-title":"Cryo-EM analysis of the conformational landscape of human P-glycoprotein (ABCB1) during its catalytic cycle","volume":"90","author":"Frank","year":"2016","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.019_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/pro.2387","article-title":"Refined structures of mouse P-glycoprotein","volume":"23","author":"Li","year":"2014","journal-title":"Protein Sci"},{"issue":"33","key":"10.1016\/j.xphs.2018.02.019_bib14","doi-asserted-by":"crossref","first-page":"13386","DOI":"10.1073\/pnas.1309275110","article-title":"Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain","volume":"110","author":"Ward","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7421","key":"10.1016\/j.xphs.2018.02.019_bib15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature11448","article-title":"Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans","volume":"490","author":"Jin","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.xphs.2018.02.019_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.str.2014.12.013","article-title":"Distinct conformational spectrum of homologous multidrug ABC transporters","volume":"23","author":"Moeller","year":"2015","journal-title":"Structure"},{"issue":"16","key":"10.1016\/j.xphs.2018.02.019_bib17","doi-asserted-by":"crossref","first-page":"10685","DOI":"10.1074\/jbc.272.16.10685","article-title":"Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis","volume":"272","author":"Rosenberg","year":"1997","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2958.2007.05792.x","article-title":"Uptake or extrusion: crystal structures of full ABC transporters suggest a common mechanism","volume":"65","author":"Dawson","year":"2007","journal-title":"Mol Microbiol"},{"issue":"48","key":"10.1016\/j.xphs.2018.02.019_bib19","doi-asserted-by":"crossref","first-page":"19005","DOI":"10.1073\/pnas.0709388104","article-title":"Flexibility in the ABC transporter MsbA: alternating access with a twist","volume":"104","author":"Ward","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.019_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568011043482142","article-title":"Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators","volume":"4","author":"Ahmad","year":"2004","journal-title":"Curr Med Chem Anticancer Agents"},{"issue":"3","key":"10.1016\/j.xphs.2018.02.019_bib21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/mol.58.3.624","article-title":"Communication between multiple drug binding sites on P-glycoprotein","volume":"58","author":"Martin","year":"2000","journal-title":"Mol Pharmacol"},{"issue":"9171","key":"10.1016\/j.xphs.2018.02.019_bib22","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0140-6736(99)03528-X","article-title":"Opioids in pain management","volume":"353","author":"McQuay","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.019_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00213-003-1718-1","article-title":"Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood\u2013brain barrier of Abcb1a gene knockout mice","volume":"173","author":"Wang","year":"2004","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.xphs.2018.02.019_bib24","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2125.2003.02053.x","article-title":"The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone","volume":"57","author":"Kharasch","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.xphs.2018.02.019_bib25","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI118699","article-title":"P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs","volume":"97","author":"Schinkel","year":"1996","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.019_bib26","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00000542-200204000-00020","article-title":"Peripheral antinociceptive action of morphine and the synergistic interaction with lamotrigine","volume":"96","author":"Arg\u00fcelles","year":"2002","journal-title":"Anesthesiology"},{"issue":"12","key":"10.1016\/j.xphs.2018.02.019_bib27","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1002\/jps.21770","article-title":"Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in\u00a0vitro and in\u00a0vivo evaluation","volume":"98","author":"Hassan","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"issue":"26","key":"10.1016\/j.xphs.2018.02.019_bib28","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2174\/138161211797440203","article-title":"Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology","volume":"17","author":"Tournier","year":"2011","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.019_bib29","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00000542-200204000-00019","article-title":"Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein","volume":"96","author":"Wandel","year":"2002","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2003.08.027","article-title":"Variable modulation of opioid brain uptake by P-glycoprotein in mice","volume":"67","author":"Dagenais","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.xphs.2018.02.019_bib31","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1023\/B:PHAM.0000045241.26925.8b","article-title":"Use of loperamide as a phenotypic probe of mdr1a status in CF-1 mice","volume":"21","author":"Kalvass","year":"2004","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2018.02.019_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/mp200563a","article-title":"P-glycoprotein-based loperamide-cyclosporine drug interaction at the rat blood-brain barrier: prediction from in\u00a0vitro studies and extrapolation to humans","volume":"9","author":"Hsiao","year":"2012","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2018.02.019_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0885-3924(99)00083-4","article-title":"Methadone: outpatient titration and monitoring strategies in cancer patients","volume":"18","author":"Hagen","year":"1999","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"7","key":"10.1016\/j.xphs.2018.02.019_bib34","first-page":"954","article-title":"Methadone inhibits\u00a0rhodamine123 transport in Caco-2 cells","volume":"29","author":"St\u00f6rmer","year":"2001","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.xphs.2018.02.019_bib35","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1017\/S1461145709990848","article-title":"Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)","volume":"13","author":"Tournier","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"issue":"8","key":"10.1016\/j.xphs.2018.02.019_bib36","doi-asserted-by":"crossref","first-page":"e22577","DOI":"10.1371\/journal.pone.0022577","article-title":"A\u00a0gene optimization strategy that enhances production of fully functional P-glycoprotein in Pichia pastoris","volume":"6","author":"Bai","year":"2011","journal-title":"PLoS One"},{"issue":"49","key":"10.1016\/j.xphs.2018.02.019_bib37","doi-asserted-by":"crossref","first-page":"34711","DOI":"10.1074\/jbc.274.49.34711","article-title":"Large scale purification of detergent-soluble P-glycoprotein from Pichia pastoris cells and characterization of nucleotide binding properties of Wild-type, Walker A, and Walker B mutant proteins","volume":"274","author":"Lerner-Marmarosh","year":"1999","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib38","doi-asserted-by":"crossref","first-page":"e00309","DOI":"10.1042\/BSR20150317","article-title":"Unravelling the complex drug\u2013drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein","volume":"36","author":"Ledwitch","year":"2016","journal-title":"Biosci Rep"},{"key":"10.1016\/j.xphs.2018.02.019_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bcp.2016.08.013","article-title":"Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein","volume":"118","author":"Ledwitch","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.xphs.2018.02.019_bib40","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.xphs.2017.02.032","article-title":"Insights into the molecular mechanism of triptan transport by P-glycoprotein","volume":"106","author":"Wilt","year":"2017","journal-title":"J\u00a0Pharm Sci"},{"issue":"51","key":"10.1016\/j.xphs.2018.02.019_bib41","doi-asserted-by":"crossref","first-page":"13686","DOI":"10.1021\/bi801409r","article-title":"Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport","volume":"47","author":"Eckford","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.xphs.2018.02.019_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bbrc.2016.02.124","article-title":"P-glycoprotein ATPase activity requires lipids to activate a switch at the first transmission interface","volume":"472","author":"Loo","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.xphs.2018.02.019_bib43","doi-asserted-by":"crossref","unstructured":"Skrzypek R, Iqbal S, Callaghan R. Methods of reconstitution to investigate membrane protein function. Methods. [Epub ahead of print] February 16, 2018.","DOI":"10.1016\/j.ymeth.2018.02.012"},{"issue":"6","key":"10.1016\/j.xphs.2018.02.019_bib44","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s002490100156","article-title":"The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence","volume":"30","author":"Rothnie","year":"2001","journal-title":"Eur Biophys J"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.019_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-2697(88)90002-4","article-title":"A\u00a0method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: application to lens ATPases","volume":"168","author":"Chifflet","year":"1988","journal-title":"Anal Biochem"},{"issue":"10","key":"10.1016\/j.xphs.2018.02.019_bib46","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1021\/ed074p1238","article-title":"Disadvantages of double reciprocal plots","volume":"74","author":"Martin","year":"1997","journal-title":"J\u00a0Chem Educ"},{"key":"10.1016\/j.xphs.2018.02.019_bib47","series-title":"Enzyme Kinetics and Mechanism","author":"Cook","year":"2007"},{"issue":"12","key":"10.1016\/j.xphs.2018.02.019_bib48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0968-0004(90)90295-M","article-title":"Using linear and non-linear regression to fit biochemical data","volume":"15","author":"Leatherbarrow","year":"1990","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0307-4412(98)00301-X","article-title":"What students must know about the determination of enzyme kinetic parameters","volume":"27","author":"Ranaldi","year":"1999","journal-title":"Biochem Educ"},{"key":"10.1016\/j.xphs.2018.02.019_bib50","series-title":"Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady State Enzyme Systems","author":"Segel","year":"1975"},{"issue":"50","key":"10.1016\/j.xphs.2018.02.019_bib51","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1021\/bi200924t","article-title":"The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4","volume":"50","author":"Roberts","year":"2011","journal-title":"Biochemistry"},{"issue":"48","key":"10.1016\/j.xphs.2018.02.019_bib52","doi-asserted-by":"crossref","first-page":"14927","DOI":"10.1021\/bi0018786","article-title":"Intrinsic fluorescence of the P-glycoprotein multidrug transporter:\u2009 sensitivity of tryptophan residues to binding of drugs and nucleotides","volume":"39","author":"Liu","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.xphs.2018.02.019_bib53","series-title":"Membrane Transporters: Methods and Protocols","first-page":"109","article-title":"Fluorescence techniques for studying membrane transport proteins","author":"Sharom","year":"2003"},{"key":"10.1016\/j.xphs.2018.02.019_bib54","series-title":"Principles of Fluorescence Spectroscopy","first-page":"954","author":"Lakowicz","year":"2011"},{"key":"10.1016\/j.xphs.2018.02.019_bib55","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1366\/000370209788964548","article-title":"Fluorescence intensity calibration using the Raman scatter peak of water","volume":"63","author":"Lawaetz","year":"2009","journal-title":"Appl Spectrosc"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib56","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1042\/BJ20060015","article-title":"Conformational and functional characterization of trapped complexes of the P-glycoprotein multidrug transporter","volume":"399","author":"Russell Paula","year":"2006","journal-title":"Biochem J"},{"issue":"25","key":"10.1016\/j.xphs.2018.02.019_bib57","doi-asserted-by":"crossref","first-page":"17649","DOI":"10.1074\/jbc.274.25.17649","article-title":"Ligand-mediated tertiary structure changes of reconstituted P-glycoprotein: a tryptophan fluorescence quenching analysis","volume":"274","author":"Sonveaux","year":"1999","journal-title":"J\u00a0Biol Chem"},{"issue":"19","key":"10.1016\/j.xphs.2018.02.019_bib58","doi-asserted-by":"crossref","first-page":"12840","DOI":"10.1074\/jbc.M708274200","article-title":"Functional characterization of Escherichia coli MsbA:\u00a0interaction with nucleotides and substrates","volume":"283","author":"Eckford","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xphs.2018.02.019_bib59","series-title":"Biostatistical Analysis","first-page":"960","author":"Zar","year":"2009"},{"issue":"25","key":"10.1016\/j.xphs.2018.02.019_bib60","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1021\/ja0100120","article-title":"Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor","volume":"123","author":"Mayer","year":"2001","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.xphs.2018.02.019_bib61","series-title":"Membrane Protein Structure and Dynamics: Methods and Protocols","first-page":"47","article-title":"Use of NMR saturation transfer difference spectroscopy to study ligand binding to membrane proteins","author":"Venkitakrishnan","year":"2012"},{"issue":"7","key":"10.1016\/j.xphs.2018.02.019_bib62","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1021\/ed101169t","article-title":"Saturation-transfer difference (STD) NMR: a simple and fast method for ligand screening and characterization of protein binding","volume":"88","author":"Viegas","year":"2011","journal-title":"J\u00a0Chem Educ"},{"issue":"3","key":"10.1016\/j.xphs.2018.02.019_bib63","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1021\/ja044434w","article-title":"Direct observation of ligand binding to membrane proteins in living cells by a saturation transfer double difference (STDD) NMR spectroscopy method shows a significantly higher affinity of integrin \u03b1IIb\u03b23 in native platelets than in liposomes","volume":"127","author":"Claasen","year":"2005","journal-title":"J\u00a0Am Chem Soc"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.019_bib64","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.bbrc.2007.05.204","article-title":"Direct detection of ligand binding to Sepharose-immobilised protein using saturation transfer double difference (STDD) NMR spectroscopy","volume":"359","author":"Haselhorst","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.xphs.2018.02.019_bib65","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF02192855","article-title":"Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions","volume":"2","author":"Piotto","year":"1992","journal-title":"J\u00a0Biomol NMR"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0925-4439(97)00026-4","article-title":"Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity","volume":"1361","author":"Litman","year":"1997","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"10.1016\/j.xphs.2018.02.019_bib67","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1021\/bi0619526","article-title":"P-Glycoprotein kinetics measured in plasma membrane vesicles and living cells","volume":"46","author":"Aanismaa","year":"2007","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.xphs.2018.02.019_bib68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/10408440802004049","article-title":"P-glycoprotein efflux transporter activity often displays biphasic dose-response relationships","volume":"38","author":"Calabrese","year":"2008","journal-title":"Crit Rev Toxicol"},{"issue":"Supplement C","key":"10.1016\/j.xphs.2018.02.019_bib69","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tiv.2015.12.009","article-title":"Heterogeneous transport of digitalis-like compounds by P-glycoprotein in\u00a0vesicular and cellular assays","volume":"32","author":"Gozalpour","year":"2016","journal-title":"Toxicol In\u00a0Vitro"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib70","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1074\/jbc.M116.755884","article-title":"Structures of the multidrug transporter P-glycoprotein reveal asymmetric ATP binding and the mechanism of polyspecificity","volume":"292","author":"Esser","year":"2017","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.xphs.2018.02.019_bib71","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbamem.2012.12.005","article-title":"P-glycoprotein is fully active after multiple tryptophan substitutions","volume":"1828","author":"Swartz","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.xphs.2018.02.019_bib72","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10863-005-9497-5","article-title":"The remarkable transport mechanism of P-glycoprotein: a multidrug transporter","volume":"37","author":"Al-Shawi","year":"2005","journal-title":"J\u00a0Bioenerg Biomembr"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib73","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1074\/jbc.M111.301192","article-title":"Dynamic ligand-induced conformational rearrangements in P-glycoprotein as probed by fluorescence resonance energy transfer spectroscopy","volume":"287","author":"Verhalen","year":"2012","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.019_bib74","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1432-1033.1997.00130.x","article-title":"Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities","volume":"250","author":"Shapiro","year":"1997","journal-title":"Eur J Biochem"},{"issue":"45","key":"10.1016\/j.xphs.2018.02.019_bib75","doi-asserted-by":"crossref","first-page":"39489","DOI":"10.1074\/jbc.M111.284554","article-title":"Conformational analysis of human ATP-binding cassette transporter ABCB1 in lipid nanodiscs and inhibition by the antibodies MRK16 and UIC2","volume":"286","author":"Ritchie","year":"2011","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib76","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1432-1033.1997.00664.x","article-title":"Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase","volume":"244","author":"Garrigos","year":"1997","journal-title":"Eur J Biochem"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib77","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0925-4439(97)00027-6","article-title":"Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity","volume":"1361","author":"Litman","year":"1997","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.xphs.2018.02.019_bib78","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1021\/jf5042307","article-title":"Demethoxycurcumin modulates human P-Glycoprotein function via uncompetitive inhibition of ATPase hydrolysis activity","volume":"63","author":"Teng","year":"2015","journal-title":"J\u00a0Agric Food Chem"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.019_bib79","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bcp.2014.10.006","article-title":"Tariquidar inhibits P-glycoprotein drug efflux but activates ATPase activity by blocking transition to an open conformation","volume":"92","author":"Loo","year":"2014","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.019_bib80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/abbi.2000.2004","article-title":"Cooperativity in the inhibition of P-glycoprotein-mediated daunorubicin transport: evidence for half-of-the-sites reactivity","volume":"383","author":"Wang","year":"2000","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"10.1016\/j.xphs.2018.02.019_bib81","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/sj.ki.5001649","article-title":"Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction","volume":"70","author":"Anglicheau","year":"2006","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib82","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-3565(24)39245-6","article-title":"Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein","volume":"293","author":"Pauli-Magnus","year":"2000","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"29","key":"10.1016\/j.xphs.2018.02.019_bib83","doi-asserted-by":"crossref","first-page":"17159","DOI":"10.1074\/jbc.270.29.17159","article-title":"Functional dissection of P-glycoprotein nucleotide-binding domains in chimeric and mutant proteins modulation of drug resistance profiles","volume":"270","author":"Beaudet","year":"1995","journal-title":"J\u00a0Biol Chem"},{"issue":"42","key":"10.1016\/j.xphs.2018.02.019_bib84","doi-asserted-by":"crossref","first-page":"13887","DOI":"10.1021\/bi991115m","article-title":"Both ATP sites of human P-glycoprotein are essential but not symmetric","volume":"38","author":"Hrycyna","year":"1999","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib85","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbamem.2007.10.021","article-title":"Structure-based interpretation of the mutagenesis database for the nucleotide binding domains of P-glycoprotein","volume":"1778","author":"Lawson","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"32","key":"10.1016\/j.xphs.2018.02.019_bib86","doi-asserted-by":"crossref","first-page":"26806","DOI":"10.1074\/jbc.M112.376202","article-title":"The ATPase activity of the P-glycoprotein drug pump is highly activated when the N-terminal and central regions of the nucleotide-binding domains are linked closely together","volume":"287","author":"Loo","year":"2012","journal-title":"J\u00a0Biol Chem"},{"issue":"45","key":"10.1016\/j.xphs.2018.02.019_bib87","doi-asserted-by":"crossref","first-page":"26956","DOI":"10.1074\/jbc.270.45.26956","article-title":"Both P-glycoprotein nucleotide-binding sites are catalytically active","volume":"270","author":"Urbatsch","year":"1995","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.019_bib88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0041-008X(03)00372-7","article-title":"Potential roles of P-gp and calcium channels in loperamide and diphenoxylate transport","volume":"193","author":"Crowe","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.019_bib89","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/PAF.0000000000000201","article-title":"Poor man's methadone a case report of loperamide toxicity","volume":"36","author":"Dierksen","year":"2015","journal-title":"Am J Forensic Med Pathol"},{"issue":"3","key":"10.1016\/j.xphs.2018.02.019_bib90","first-page":"20","article-title":"The impact of permeability enhancers on assessment for monolayer of colon adenocarcinoma cell line (CACO-2) used in in\u00a0vitro permeability assay","volume":"3","author":"Himanshu","year":"2013","journal-title":"J\u00a0Drug Deliv Therap"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.019_bib91","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1213\/ane.0b013e31818e0bd1","article-title":"Competitive substrates for P-glycoprotein and organic anion protein transporters differentially reduce blood organ transport of fentanyl and loperamide: pharmacokinetics and pharmacodynamics in Sprague-Dawley rats","volume":"108","author":"Elkiweri","year":"2009","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.019_bib92","doi-asserted-by":"crossref","first-page":"e1600001","DOI":"10.1126\/sciadv.1600001","article-title":"Global marine pollutants inhibit P-glycoprotein: environmental levels, inhibitory effects, and cocrystal structure","volume":"2","author":"Nicklisch","year":"2016","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib93","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J\u00a0Neurochem"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.019_bib94","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","article-title":"Role of P-glycoprotein in pharmacokinetics","volume":"42","author":"Lin","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.019_bib95","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/dmd.107.017434","article-title":"In\u00a0vitro P-glycoprotein assays to predict the in\u00a0vivo interactions of P-glycoprotein with drugs in the central nervous system","volume":"36","author":"Feng","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.xphs.2018.02.019_bib96","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/156802611795371288","article-title":"Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance","volume":"11","author":"Mercer","year":"2011","journal-title":"Curr Top Med Chem"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918301369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918301369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:23:52Z","timestamp":1758360232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918301369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":96,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0022354918301369"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.02.019","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Conformationally Gated Model of Methadone and Loperamide Transport by P-Glycoprotein","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}